Cases
Representative Matters: Sale
acquisition of insurance brokerage agencies (approximately 35 plus transactions aggregating $600 million in upfront value to date)
Recently represeted a publicly traded clinical stage company specializing in innovative cancer treatment therapies, in a share exchange with a privately owned Mexican pharmaceutical company developing
commercializing specialty drugs.
Recently represented one of the five firms currently engaged in the medical marijuana business in the State of New York as a licensed Registered Organization under the New York State Public Health Law, in the sale of its stock to an affiliate of a private equity fund
Recently represented a major lending institution in connection with a $75 million Reducing Revolving Credit Facility
$2 million Letter of Credit Facility for a NYSE telecommunications company
Recently represented a major lending institution in connection with a $625 million Credit Facility for a regional sports program, service
broadcast channel
Recently represented a major lending institution in connection with a $250 million senior secured Credit Facility for a professional sports team
Recently represented a publicly traded non-physician owned healthcare services company in acquiring controlling interest in an orthoaedic spine
interventional pain medicine company
an accredited ambulatory surgery center
Recently represented a healthcare company in connection with the acquisition of a product line
a manufacturing facility from a private equity owned firm
Recently represented a major lending institution in connection with a $100,000,000 syndicated Revolving Credit Facility, Non-Revolving Credit Facility
Term Loan to the largest regional owner
operator of fuel centers
convenience stores
Recently represented a major lending institution in connection with an Amended
Restated Revolving Credit Facility in the principal amount of $12,000,000 to a leading retailer in the office furniture industry
Recently completed the sale of $6,500,000 of Series A Preferred Stock for a New Jersey manufacturer of computer memory
software products
Recently completed the sale of $750,000 of Subordinated Secured Convertible Bridge Notes
Common Stock Purchase Warrants to institutional investors for a manufacturer of computer
software products
Filed an S-1 registration statement in a firm commitment underwriting
Completed a registered direct offering of common stock
warrants for a publicly traded technology company
Successfully reorganized the debt structure of a publicly traded technology company with a multimillion dollar convertible Preferred Stock Offering
Completed the multimillion dollar sale of intellectual property
purchase of controlling interest of a Canadian corporation through a convertible note, warrant
stock purchase agreement for a publicly traded technology company
Mr. Satin published an article entitled Say in Pay
Beyond
was a panelist at several seminars: Hot Topics in Securities Law: A Private Roundtable for Public Companies
Their Advisors, Current Trends
Developments in Corporate
Securities Law, Crowdfunding - Accounting
Legal Perspectives from Traditional
Emerging Enterprises,
Don't be left behind: Tax Strategies
Deal Terms in M & A.
Prior to joining Schnader, Mr. Satin was a partner at Meyer, Suozzi, English & Klein, P.C
of counsel to Ruskin, Moscou, Faltischek, P.C. From 1993 to 2009, Mr. Satin was Vice President, General Counsel
a member of the Board of Directors of Medical Action Industries Inc. Mr. Satin served as the Chief Legal Officer of the company
was responsible for all aspects of Medical Action's legal affairs around the world. In addition, from 1994 to 2008, Mr. Satin served as Medical Action's Principal Financial Officer.
